Head-to-Head

Atossa Therapeutics, Inc. Common Stock vs. Johnson & Johnson

ATOS

Atossa Therapeutics, Inc. Common Stock

$2.02 -4.72%

VS JNJ

Johnson & Johnson

$276.22 +1.43%

Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ATOSJNJ
Market Cap $21.16 million $655.56 billion

JNJ leads on 1 of 1 size & scale factors.

Dividend

ATOSJNJ
Dividend Yield — 1.94%

ATOS and JNJ split the dividend factors evenly.

Risk & Sentiment

ATOSJNJ
Short Interest 15.54% 0.67%

JNJ leads on 1 of 1 risk & sentiment factors.

Dig deeper: ATOS overview, ATOS financials, JNJ overview, JNJ financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.